Intestinal microbiome is related to lifetime antibiotic use in Finnish pre-school children
Open accessThe DOI matches its Crossref record; 63 of the 64 references it cites were found in a registry or an index.
Abstract
Early-life antibiotic use is associated with increased risk for metabolic and immunological diseases, and mouse studies indicate a causal role of the disrupted microbiome. However, little is known about the impacts of antibiotics on the developing microbiome of children. Here we use phylogenetics, metagenomics and individual antibiotic purchase records to show that macrolide use in 2-7 year-old Finnish children (N=142; sampled at two time points) is associated with a long-lasting shift in microbiota composition and metabolism. The shift includes depletion of Actinobacteria, increase in Bacteroidetes and Proteobacteria, decrease in bile-salt hydrolase and increase in macrolide resistance. Furthermore, macrolide use in early life is associated with increased risk of asthma and predisposes to antibiotic-associated weight gain. Overweight and asthmatic children have distinct microbiota compositions. Penicillins leave a weaker mark on the microbiota than macrolides. Our results support the idea that, without compromising clinical practice, the impact on the intestinal microbiota should be considered when prescribing antibiotics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“an induction of ARGs, and a decrease in bile salt hydrolases”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [89]
In the citing paper
“Such profile positively correlated with either a later development of asthma, or an increase in body mass index [89].”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [89]
In the citing paper
“Early use of macrolides in Finnish children was found to generate a distinct microbial profile characterized by a loss of Actinobacteriaceae and an increase in Bacteroidetes and Proteobacteria”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [89]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
QIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887
Modern Applied Statistics with S
Venables, W. N., & Ripley, B. D. (2002) · Statistics and Computing · doi:10.1007/978-0-387-21706-2 · Cited by 24,305
UCHIME improves sensitivity and speed of chimera detection
Edgar, R. C., Haas, B. J., Clemente, J. C., Quince, C., & Knight, R. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr381 · Cited by 15,114
The control of the false discovery rate in multiple testing under dependency
Benjamini, Y., & Yekutieli, D. (2001) · The Annals of Statistics · doi:10.1214/aos/1013699998 · Cited by 10,490
Klindworth, A., Pruesse, E., Schweer, T., Peplies, J., Quast, C., Horn, M., & Glöckner, F. O. (2013) · Nucleic Acids Research · doi:10.1093/nar/gks808 · Cited by 8,850
Metabolic Endotoxemia Initiates Obesity and Insulin Resistance
Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A. M., Fava, F., Tuohy, K. M., Chabo, C., et al. (2007) · Diabetes · doi:10.2337/db06-1491 · Cited by 6,638
Richness of human gut microbiome correlates with metabolic markers
Le Chatelier, E., Nielsen, T., Qin, J., Prifti, E., Hildebrand, F., Falony, G., Almeida, M., Arumugam, M., Batto, J.-M., Kennedy, S., et al. (2013) · Nature · doi:10.1038/nature12506 · Cited by 4,662
Human Genetics Shape the Gut Microbiome
Goodrich, J. K., Waters, J. L., Poole, A. C., Sutter, J. L., Koren, O., Blekhman, R., Beaumont, M., Van Treuren, W., Knight, R., Bell, J. T., et al. (2014) · Cell · doi:10.1016/j.cell.2014.09.053 · Cited by 3,164
Waste Not, Want Not: Why Rarefying Microbiome Data Is Inadmissible
McMurdie, P. J., & Holmes, S. (2014) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003531 · Cited by 2,921
Bile salt biotransformations by human intestinal bacteria
Ridlon, J. M., Kang, D.-J., & Hylemon, P. B. (2006) · Journal of Lipid Research · doi:10.1194/jlr.r500013-jlr200 · Cited by 2,829
Cited by
Items 301–400 of 698
Effect of antibiotics in the first week of life on faecal microbiota development
Daele, E. V., Kamphorst, K., Vlieger, A. M., Hermes, G. D. A., Milani, C., Ventura, M., Belzer, C., Smidt, H., van Elburg, R. M., & Knol, J. (2022) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/archdischild-2021-322861 · Cited by 30
A history of repeated antibiotic usage leads to microbiota-dependent mucus defects
Krigul, K. L., Feeney, R. H., Wongkuna, S., Aasmets, O., Holmberg, S. M., Andreson, R., Puértolas-Balint, F., Pantiukh, K., Sootak, L., Org, T., et al. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2377570 · Cited by 26
“With the dramatic rise in global antibiotic use in recent years, an increase in various complex diseases, including asthma (Korpela et al., 2016), allergies (Hirsch et al., 2017), celiac disease (Mårild et al., 2013), diabetes (Livanos et al., 2016) and chronic inflammatory diseases of the…”
BackgroundXin, L., He, F., Li, S., Zhou, Z., & Ma, X. (2020) · World Journal of Pediatrics · doi:10.1007/s12519-020-00371-3 · Cited by 29
Siu, J., Mackenzie, B. W., Klingler, L., Biswas, K., Wang, Y., Hung, C., Jeong, S. H., Barnett, D. B., Tingle, M. D., & Douglas, R. G. (2021) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22799 · Cited by 25
Ciprofloxacin for treatment of drug-resistant epilepsy
Cheraghmakani, H., Rezai, M. S., Valadan, R., Rahimzadeh, G., Moradi, M., Jahanfekr, V., Moosazadeh, M., & Tabrizi, N. (2021) · Epilepsy Research · doi:10.1016/j.eplepsyres.2021.106742 · Cited by 23
Bornbusch, S. L., Harris, R. L., Grebe, N. M., Roche, K. E., Dimac-Stohl, K. A., & Drea, C. M. (2021) · Animal Microbiome · doi:10.1186/s42523-021-00126-z · Cited by 27
“The ability to recolonize or re-diversify a microbiome after a perturbation can be severely dampened by injury or disease [61, 62] and by recurrent antibiotic treatment [63, 64].”
BackgroundAntibiotics biomonitored in urine and obesogenic risk in a community-dwelling elderly population
Sang, Y., Zhang, J., Liu, K., Wang, Q., Wang, S., Sheng, J., Wang, L., Zhang, D., Li, X., Cao, H., et al. (2021) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2020.111863 · Cited by 25
Environmental exposures and child and maternal gut microbiota in rural Malawi
Kortekangas, E., Kamng’ona, A. W., Fan, Y., Cheung, Y. B., Ashorn, U., Matchado, A., Poelman, B., Maleta, K. M., Dewey, K. G., & Ashorn, P. (2020) · Paediatric and Perinatal Epidemiology · doi:10.1111/ppe.12623 · Cited by 29
Antibiotic use for Australian Aboriginal children in three remote Northern Territory communities
Howarth, T. P., Brunette, R., Davies, T., Andrews, R. M., Patel, B. K., Tong, S. Y. C., Barzi, F., & Kearns, T. (2020) · PLoS ONE · doi:10.1371/journal.pone.0231798 · Cited by 23
“[32] According to a 2016 report, the burden of disease among Aboriginal Australians is 2.”
BackgroundThe microbiome in pediatric oncology
Rotz, S. J., & Dandoy, C. E. (2020) · Cancer · doi:10.1002/cncr.33030 · Cited by 25
“In neonates and young children, treatment with antibiotics leads to long-term changes in the microbiome.(14,78,79) Although cancer therapy clearly changes the microbiome during treatment, to our knowledge it is less clear whether these alterations persist in the long term.”
BackgroundZeineldin, M. M., Megahed, A., Burton, B., Blair, B., Aldridge, B. M., & Lowe, J. F. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01414 · Cited by 27
Antibiotics-Induced Obesity: A Mitochondrial Perspective
Andrade, M. J., Jayaprakash, C., Bhat, S., Evangelatos, N. G., Brand, A. M., & Satyamoorthy, K. (2017) · Public Health Genomics · doi:10.1159/000485095 · Cited by 25
Can Helicobacter pylori Eradication Treatment Modify the Metabolic Response to Bariatric Surgery?
Goday, A., Castañer, O., Benaiges, D., Pou, A. B., Ramón, J. M., Iglesias, M. D. M., Priego, L. B., & Roux, J. A. F. (2018) · Obesity Surgery · doi:10.1007/s11695-018-3170-7 · Cited by 27
“diversity as well as an increase of relative abundance of Bacteroidetes and Proteobacteria [15].”
BackgroundThomas, S. P., Denizer, E., Zuffa, S., Best, B. M., Bode, L., Chambers, C., Dorrestein, P. C., Liu, G. Y., Momper, J. D., Nizet, V., et al. (2022) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2732 · Cited by 22
Zhang, Y., Xue, G., Wang, F., Zhang, J., Xu, L., & Yu, C. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1382332 · Cited by 35
“…for resistant pathogens that cause subsequent infections (Ianiro et al., 2020; De Nies et al., 2023), and antibiotics targeting specific species may also act on commensal species in patients (Korpela et al., 2016; Yang et al., 2021), thereby collectively disrupting microbial community stability.”
BackgroundSun, Y., He, Z., Li, J., Gong, S., Yuan, S., Li, T., Ning, N., Xing, L., Zhang, L., Chen, F., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.608895 · Cited by 23
“A review of pediatric literature showed that growth promotion by antibiotics (7), when it was observed, was mostly mediated by its antiinfective properties.”
BackgroundAuguet, O. T., Niehus, R., Gweon, H. S., Berkley, J. A., Waichungo, J., Njim, T. N., Edgeworth, J. D., Batra, R., Chau, K., Swann, J., et al. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.100910 · Cited by 24
Therapeutic evaluation of immunomodulators in reducing surgical wound infection
Mahmud, F., Roy, R., Mohamed, M. F., Aboonabi, A., Moric, M. M., Ghoreishi, K., Bayat, M., Kuzel, T. M., Reiser, J., & Shafikhani, S. H. (2021) · The FASEB Journal · doi:10.1096/fj.202101019r · Cited by 27
Dunn, K. A., MacDonald, T., Rodrigues, G. J., Forbrigger, Z., Bielawski, J. P., Langille, M. G. I., Limbergen, J. V., & Kulkarni, K. P. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.924707 · Cited by 23
Li, H., Xi, Y., Xin, X., Feng, Q., & Hu, Y. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1148737 · Cited by 25
“…of pathogenic microorganisms that increase the levels of their related metabolites in the gut, which eventually get into the bloodstream and cause human diseases such as obesity (Korpela et al., 2016), diabetes (Muñoz-Garach et al., 2016), and in fl ammatory bowel disease (Sokol et al., 2017).”
Longitudinal effects of oral administration of antimicrobial drugs on fecal microbiota of horses
Gómez, D. E., Toribio, R. E., Caddey, B., Costa, M., Vijan, S., & Dembek, K. A. (2023) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.16853 · Cited by 24
“33,34 Here, we show that oral administration of frequently used antimicrobial drugs to healthy horses causes changes in the diversity and bacterial structure of GI microbiota.”
BackgroundGut microbiome associated dysbiosis: Limited regimens and expanding horizons of phage therapy
Singha, B., Rawat, B. S., Venkataraman, R., Nair, T., Rosenn, E. H., & Soni, V. (2023) · Aspects of Molecular Medicine · doi:10.1016/j.amolm.2023.100029 · Cited by 26
Sinha, T., Prins, J. R., Fernández-Pato, A., Kruk, M., Dierikx, T. H., de Meij, T. G. J., de Boer, M. A., de Boer, J. F., Scherjon, S. A., Kurilshikov, A., et al. (2024) · Cell Host & Microbe · doi:10.1016/j.chom.2024.07.010 · Cited by 20
“…diseases in infants, 15 the emerging prominent role of BAs in the establishing and maturation of the early gut microbiome in murine models 16 as well as the associations ofBAwithantibioticadministrationininfants, 17 wealso quantified 18 BAs in the feces of infant samples at weeks 1, 4, and 6.”
BackgroundAntibiotic Use in Early Life, Rural Residence, and Allergic Diseases in Argentinean Children
Han, Y., Forno, E., Badellino, H., & Celedon, J. C. (2017) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2016.12.025 · Cited by 26
Nikolaou, E., Kamilari, E., Savkov, D., Sergeev, A., Zakharova, I. N., Vogazianos, P., Tomazou, M., Antoniades, A., & Shammas, C. (2019) · World Journal of Pediatrics · doi:10.1007/s12519-019-00315-6 · Cited by 21
Shaping oral and intestinal microbiota and the immune system during the first 1,000 days of life
Zhu, J., He, M., Li, S., Lei, Y., Xiang, X., Guo, Z., & Wang, Q. (2025) · Frontiers in Pediatrics · doi:10.3389/fped.2025.1471743 · Cited by 28
Mohandas, S., Soma, V. L., Tran, T. D. B., Sodergren, E. J., Ambooken, T., Goldman, D. L., Weinstock, G. M., & Herold, B. C. (2020) · Frontiers in Pediatrics · doi:10.3389/fped.2020.583446 · Cited by 29
Sarlin, S., Tejesvi, M. V., Turunen, J., Vänni, P., Pokka, T. M.-L., Renko, M., & Tapiainen, T. (2020) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000003016 · Cited by 21
MetaCache-GPU: Ultra-Fast Metagenomic Classification
Kobus, R., Müller, A., Jünger, D., Hundt, C., & Schmidt, B. (2021) · Proceedings of the International Conference on Parallel Processing · doi:10.1145/3472456.3472460 · Cited by 23
Microbiome systems biology advancements for natural well-being
Chatterjee, G., Negi, S., Basu, S., Faintuch, J., O’Donovan, A., & Shukla, P. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.155915 · Cited by 24
Pravda, J. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i31.4263 · Cited by 29
Zhan, M., Liang, X., Chen, J., Yang, X., Han, Y., Zhao, C., Xiao, J., Cao, Y., Xiao, H., & Song, M. (2023) · Food & Function · doi:10.1039/d3fo00516j · Cited by 21
Luo, Q., Zhou, P., Chang, S., Huang, Z., & Zhu, Y. (2023) · Heart & Lung · doi:10.1016/j.hrtlng.2023.05.016 · Cited by 22
O’Donovan, C. M., Connor, B., Madigan, S. M., Cotter, P. D., & Sullivan, O. O. (2020) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2020.101553 · Cited by 21
Gawlik, A., Salonen, A., Jian, C., Yanover, C., Antosz, A., Shmoish, M., Wasniewska, M. G., Bereket, A., Wudy, S. A., Hartmann, M. F., et al. (2021) · Pediatric Obesity · doi:10.1111/ijpo.12835 · Cited by 20
Inflammatory bowel disease - glycomics perspective
Hanić, M., Trbojević‐Akmačić, I., & Lauc, G. (2019) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2019.07.001 · Cited by 21
Olshan, K. L., Zomorrodi, A. R., Pujolassos, M., Troisi, J., Khan, N., Fanelli, B. C., Kenyon, V., Fasano, A., & Leonard, M. M. (2021) · Nutrients · doi:10.3390/nu13072243 · Cited by 22
“Many factors are known to alter the composition of the intestinal microbiota, including exposure to antibiotics [10], exposure to other medications [11,12], and dietary patterns [13].”
BackgroundThe hidden threat: Environmental toxins and their effects on gut microbiota
Bhardwaj, G., Riadi, Y., Afzal, M., Bansal, P., Kaur, H., Deorari, M., Tonk, R. K., Almalki, W. H., Kazmi, I. A., Alzarea, S. I., et al. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155173 · Cited by 22
Xiao, P., Shen, C., Li, Y., Cui, S., Chen, S., & Yang, J. (2024) · Journal of the Taiwan Institute of Chemical Engineers · doi:10.1016/j.jtice.2024.105611 · Cited by 19
Antibacterial Monoclonal Antibodies Do Not Disrupt the Intestinal Microbiome or Its Function
Jones-Nelson, O., Tovchigrechko, A., Glover, M. S., Fernandes, F., Rangaswamy, U. S., Liu, H., Tabor, D. E., Boyd, J., Warrener, P., Martínez, J. L., et al. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02347-19 · Cited by 23
“Also, children administered antibiotics during the first year of life were found to exhibit an increased risk for developing asthma and childhood obesity (12, 13).”
Evolution, the Immune System, and the Health Consequences of Socioeconomic Inequality
Rook, G. A. W. (2022) · mSystems · doi:10.1128/msystems.01438-21 · Cited by 25
“…medical interventions and relatively uniform access to antibiotics, the risk of receiving multiple antibiotic prescriptions in pregnancy and childhood is related to poor parental educational level (154), and in Finland changes in the microbiota have been linked to early-life antibiotic use (155).”
BackgroundThe Use of Gut Microbial Modulation Strategies as Interventional Strategies for Ageing
Siddiqui, R., Mungroo, M. R., Alharbi, A. M., Alfahemi, H. H., & Khan, N. A. (2022) · Microorganisms · doi:10.3390/microorganisms10091869 · Cited by 21
Bruk av antibiotika hos barn i perioden 2005 – 16
Størdal, K., Mårild, K., & Blix, H. S. (2017) · Tidsskrift for Den norske legeforening · doi:10.4045/tidsskr.17.0272 · Cited by 18
Xia, Y., Lan, Y., Xu, Y., Liu, F., Chen, X., Luo, J., Xu, H., & Liu, Y. (2025) · Environment International · doi:10.1016/j.envint.2025.109512 · Cited by 19
Wang, Z., Yu, J., Liu, Y., Gong, J., Hu, Z., & Liu, Z. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1636876 · Cited by 28
“Pneumonia can affect the composition of the gut microbiota, primarily leading to a decrease in Bi fi dobacterium (10), Lactobacillus (69), and Clostridium (70), and causing an increase in Escherichia coli (59).”
InfluentialHamilton, J., Mohamed, M. F., Witt, B., Wimmer, M. A., & Shafikhani, S. H. (2021) · European Cells and Materials · doi:10.22203/ecm.v042a09 · Cited by 18
“…and allergic reactions, and the success rates after these treatments are abysmal, often ranging between 50 to 70 % (Becattini et al., 2016; Jakobsson et al., 2010; Korpela et al., 2016; Langdon et al., 2016; Pelt et al., 2014; Sampson et al., 2016; Segawa et al., 1999; Yassour et al., 2016).”
BackgroundOuyang, J., Zaongo, S. D., Zhang, X., Qi, M., Hu, A., Wu, H., & Chen, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.755890 · Cited by 18
The human gut microbiome – a new and exciting avenue in cardiovascular drug discovery
Du, Y., Li, X., Su, C., Wang, L., Jiang, J., & Hong, B. (2019) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2019.1638909 · Cited by 21
Gut microbiome and anti-viral immunity in COVID-19
Rossini, V., Tolosa-Enguís, V., Francés‐Cuesta, C., & Sanz, Y. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2143476 · Cited by 21
“For example, the use of antibiotics, which disrupt the microbiota in early life, has been associated with a higher risk of developing asthma (Korpela et al. 2016).”
BackgroundLifestyle alters GUT-bacteria function: Linking immune response and host
Jazayeri, O., Daghighi, S. M., & Rezaee, F. (2017) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2017.09.009 · Cited by 21
Wu, G., Wang, R., Wang, Y., Sun, S., Chen, J., & Zhang, Q. (2025) · Foods · doi:10.3390/foods14223836 · Cited by 21
“These microbial alterations are associated with elevated risks of asthma and obesity in later childhood [123].”
Cuningham, W., McVernon, J., Lydeamore, M., Andrews, R. M., Carapetis, J. R., Kearns, T., Clucas, D. B., Dhurrkay, R. G., Tong, S. Y. C., & Campbell, P. T. (2019) · Australian and New Zealand Journal of Public Health · doi:10.1111/1753-6405.12876 · Cited by 17
Changes in the Gut Microbiota May Affect the Clinical Efficacy of Oral Anticoagulants
Chen, W., Qian, J., Fu, J., Wu, T., Lv, M., Jiang, S., & Zhang, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.860237 · Cited by 21
“Similar to the reports of other studies (Stewardson et al., 2015; Korpela et al., 2016; Kuno et al., 2016), the gut microbiota of the rats changed its structure and composition after exposure to antibiotics.”
ResultBaek, M. S., Kim, S., Kim, W., Kweon, M., & Huh, J. W. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1140402 · Cited by 19
A Spectrum of Solutions: Unveiling Non-Pharmacological Approaches to Manage Autism Spectrum Disorder
Mondal, A., Sharma, R., Abiha, U., Ahmad, F., Karan, A., Jayaraj, R. L., & Sundar, V. (2023) · Medicina · doi:10.3390/medicina59091584 · Cited by 26
Metz, T. D., McKinney, J., Allshouse, A. A., Knierim, S. D., Carey, J. C., & Heyborne, K. (2019) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2019.1571575 · Cited by 21
Improving glucose and lipids metabolism: drug development based on bile acid related targets
Shen, H., Ding, L., Baig, M., Tian, J., Wang, Y., & Huang, W. (2021) · Cell Stress · doi:10.15698/cst2021.01.239 · Cited by 20
Liu, X., Qiu, X., Yang, Y., Wang, J., Wang, Q., Liu, J., Yang, F., Liu, Z., & Qi, R. (2022) · iScience · doi:10.1016/j.isci.2023.106190 · Cited by 22
“Furthermore, the number of some beneficial bacteria (such as Lactobacillus andAnaerostipes) still declines even after the withdrawal of antibiotics, and it is difficult to restore the original state fully.(3) Therefore, to reduce or eliminate the side effects of antibiotic treatment, new strategies are urgently needed…”
BackgroundInfluence of gut microbiota on autoimmunity: A narrative review
Sai, A., Shetty, G. B., Shetty, P., & Nanjeshgowda, H. L. (2024) · Brain Behavior and Immunity Integrative · doi:10.1016/j.bbii.2024.100046 · Cited by 20
Gauglitz, J. M., Morton, J. T., Tripathi, A., Hansen, S., Gaffney, M., Carpenter, C. S., Weldon, K. C., Shah, R., Parampil, A., Fidgett, A., et al. (2020) · mSystems · doi:10.1128/msystems.00635-19 · Cited by 15
Kolmeder, C. A., & de Vos, W. M. (2020) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2020.113751 · Cited by 17
The effects of antibiotic exposure on asthma in children with atopic dermatitis
Chen, I., Tsai, M.-K., Chung, H., Hsieh, H., Huang, Y.-T., Lin, Y.-C., & Hung, C. (2021) · Scientific Reports · doi:10.1038/s41598-021-87981-7 · Cited by 18
Thaulow, C. M., Berild, D., Eriksen, B. H., Myklebust, T. Å., & Blix, H. S. (2018) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000002106 · Cited by 16
Wu, Z., & Wang, H. X. (2018) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-018-0033-4 · Cited by 22
“Macrolides Bacteroidetes↑ Bifidobacteria↓ Christensenellaceae↓ Proteobacteria↑ Human [37, 38] Erysipelotrichaceae↑ Actinobacteria↓”
Karimianghadim, R., Satokari, R. M., Yeo, S., Arkkila, P. E. T., Kao, D. H., & Pakpour, S. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1589704 · Cited by 18
“…functions may take significantly longer to return to baseline levels (Dethlefsen and Relman, 2011; Palleja et al., 2018; Raymond et al., 2016), highlighting a gap in donor requalification practices (Dethlefsen and Relman, 2011; Jernberg et al., 2007; Korpela et al., 2016; Ng et al., 2019).”
Räisänen, L., Kääriäinen, S., Sund, R., Engberg, E., Viljakainen, H. T., & Kolho, K. (2022) · Pediatric Research · doi:10.1038/s41390-022-02188-4 · Cited by 17
Modeling the potential health impact of prospective Strep A vaccines
Giannini, F., Cannon, J. W., Cadarette, D., Bloom, D. E., Moore, H. C., Carapetis, J. R., & Abbas, K. (2023) · npj Vaccines · doi:10.1038/s41541-023-00668-0 · Cited by 18
“It may also reduce the risk of microbiome disruption, which is hypothesised to lead to chronic health conditions 32 .”
Patient, Provider, and Health Care System Characteristics Associated With Overuse in Bronchiolitis
Wolf, E. R., Richards, A., Lavallee, M., Sabo, R., Schroeder, A. R., Schefft, M., & Krist, A. H. (2021) · PEDIATRICS · doi:10.1542/peds.2021-051345 · Cited by 16
Kenyon, C. R., Vanbaelen, T., & Dijck, C. V. (2022) · International Journal of STD & AIDS · doi:10.1177/09564624211064133 · Cited by 17
“Both have a large effect on human microbiomes.(68,71) Screening PrEP cohorts for gonorrhoea/ chlamydia three monthly, as advocated in numerous countries results in the consumption of approximately 12 defined daily doses per 1000 inhabitants per year (DID) macrolides.”
BackgroundSoil exposure accelerates recovery of the gut microbiota in antibiotic‐treated mice
Li, N., Zhang, H., Bai, Z., Jiang, H., Yang, F., Sun, X. S., Lu, Z., & Zhou, D. (2021) · Environmental Microbiology Reports · doi:10.1111/1758-2229.12959 · Cited by 14
Pescari, D., Mihuţa, M. S., Bena, A., & Stoian, D. (2025) · Nutrients · doi:10.3390/nu17050798 · Cited by 15
Early Childhood Antibiotics and Chronic Pediatric Conditions: A Retrospective Cohort Study
Beier, M. A., Setoguchi, S., Gerhard, T., Roy, J., Koffman, D., Mendhe, D., Madej, J., Strom, B. L., Blaser, M. J., & Horton, D. B. (2025) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaf191 · Cited by 19
Guo, Y., Zhang, N., & Pei, D. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1645298 · Cited by 18
Mass drug administration of antibacterials: weighing the evidence regarding benefits and risks
Rolfe, R. J., Shaikh, H., & Tillekeratne, L. G. (2022) · Infectious Diseases of Poverty · doi:10.1186/s40249-022-00998-6 · Cited by 15
“Chronic diseases Antibacterial consumption has been linked to chronic diseases such as obesity, asthma, and inflammatory bowel disease through mechanisms that are thought to be related to alteration of the gut microbiome [49].”
BackgroundCorrelating the Gut Microbiome to Health and Disease
Marques, T. M., Holster, S., Wall, R., König, J., Brummer, R. J., & de Vos, W. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802304-4.00012-8 · Cited by 16
Kwong, C. G., & Bacharier, L. B. (2017) · Current Allergy and Asthma Reports · doi:10.1007/s11882-017-0701-6 · Cited by 19
Depletion of Gram-Positive Bacteria Impacts Hepatic Biological Functions During the Light Phase
Oh, H. Y. P., Ellero‐Simatos, S., Manickam, R., Tan, N. S., Guillou, H., & Wahli, W. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040812 · Cited by 14
“Antibiotics have been used extensively in various studies aiming at assessing the impact of gut microbe alterations in chronic inflammatory diseases, diabetes, and metabolic syndrome [27,28].”
BackgroundKoo, H., Crossman, D. K., & Morrow, C. D. (2020) · Frontiers in Pediatrics · doi:10.3389/fped.2020.549844 · Cited by 14
Richards-Rios, P., Wigley, P., López, J., Wormell, D., & Barbón, A. R. (2021) · Animal Microbiome · doi:10.1186/s42523-020-00062-4 · Cited by 14
“Given that antibiotic treatment has been shown to affect the microbiome of humans [30, 33], the cause of disturbances in the microbiota in affected marmosets may be related to higher levels of antibiotic treatment.”
BackgroundPettersen, V. K., Antunes, L. C. M., Dufour, A., & Arrieta, M. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.12.012 · Cited by 16
“The gut microbiome has been linked to the development and progression of both infectious [5] and chronic non-communicable diseases [6,7], including cancer [8], autoimmune [9], and neurological disorders [10].”
BackgroundMetabolic phenotyping of the human microbiome
Barton, W., O’Sullivan, Ó., & Cotter, P. D. (2019) · F1000Research · doi:10.12688/f1000research.19481.1 · Cited by 16
Can we back off using antibiotics in the NICU?
Fleiss, N., Hooven, T. A., & Polin, R. A. (2021) · Seminars in Fetal and Neonatal Medicine · doi:10.1016/j.siny.2021.101217 · Cited by 16
Carpén, N., Brodin, P., de Vos, W. M., Salonen, A., Kolho, K., Andersson, S., & Helve, O. (2022) · BMC Pediatrics · doi:10.1186/s12887-022-03609-3 · Cited by 16
Abbas, W., Bi, R., Hussain, M. D., Tajdar, A., Guo, F., Guo, Y., & Wang, Z. (2024) · Antibiotics · doi:10.3390/antibiotics13050413 · Cited by 16
“The microbial community’s symbiosis with the host helps to maintain homeostasis and regulate immune responses [4].”
BackgroundFarmer, N., Morton, V. H., & Morris, R. K. (2019) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2019.11.026 · Cited by 16
Lu, C., Tian, Y., Tian, H., Li, B., Peng, B., Zheng, J., & Dai, Y. (2022) · Science China Materials · doi:10.1007/s40843-022-2125-1 · Cited by 13
Yamamoto‐Hanada, K., Pak, K., Saito‐Abe, M., Sato, M., Miyaji, Y., Mezawa, H., Nishizato, M., Yang, L., Kumasaka, N., Nomura, I., et al. (2023) · Clinical & Experimental Allergy · doi:10.1111/cea.14286 · Cited by 12
Long-term dysbiosis and fluctuations of gut microbiome in antibiotic treated preterm infants
Çetinbaş, M., Thai, J. D., Filatava, E. J., Gregory, K. E., & Sadreyev, R. I. (2023) · iScience · doi:10.1016/j.isci.2023.107995 · Cited by 14
Rook, G. A. W. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105653 · Cited by 12
Tan, R., Jin, M., Lǐ, J., & Yang, D. (2025) · Journal of Hazardous Materials Advances · doi:10.1016/j.hazadv.2025.100634 · Cited by 24
Shayista, H., Prasad, M. N. N., Raj, S. N., Prasad, A., Satish, S., Ranjini, H. K., Manju, K. G., Ravikumara, Chouhan, R. S., Khohlova, O. Y., et al. (2025) · Medicine in Microecology · doi:10.1016/j.medmic.2025.100122 · Cited by 20
Kaur, N., Kumar, P., Dhami, M., & Aran, K. R. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10425-2 · Cited by 16
“On the other hand, macrolides administration increased the risk of obesity, and long-term GM imbalance, which further can result in CVDs [46].”
van Olst, N., Meiring, S., de Brauw, M., Bergman, J. J. G. H. M., Nieuwdorp, M., van der Peet, D. L., & Gerdes, V. E. A. (2020) · Techniques and Innovations in Gastrointestinal Endoscopy · doi:10.1016/j.tige.2020.03.003 · Cited by 13
Temporal Dynamics of Chronic Inflammation on the Cecal Microbiota in IL-10-/- Mice
Overstreet, A.-M. C., Ramer‐Tait, A. E., Suchodolski, J. S., Hostetter, J. M., Wang, C., Jergens, A. E., Phillips, G. J., & Wannemuehler, M. J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.585431 · Cited by 12
“revealed that children prescribed macrolide antibiotics between 2-7 years of age had a reduction in microbial richness even 24 months after antibiotic exposure (74).”
BackgroundOlekhnovich, E. I., Ivanov, A. B., Игоревич, У. В., & Ilina, E. N. (2021) · mSystems · doi:10.1128/msystems.00811-21 · Cited by 13
“transmission, feeding (breastfeeding or artificial) (2–4), and early antibiotic therapy (5).”
BackgroundLi, M., Qian, W., Yu, L., Tian, F., Zhang, H., Chen, W., Xue, Y., & Zhai, Q. (2022) · Microorganisms · doi:10.3390/microorganisms10122317 · Cited by 13
Human matters in asthma: Considering the microbiome in pulmonary health
Marathe, S. J., Snider, M. A., Flores-Torres, A. S., Dubin, P. J., & Samarasinghe, A. E. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1020133 · Cited by 16
“Others such as vitamin K are predominantly produced by Firmicutes, Proteobacteria, and Bacteroidetes in the gut (Ravcheev and Thiele, 2016).”
BackgroundInfluentialA Prospective Study on Child Morbidity and Gut Microbiota in Rural Malawi
Kortekangas, E., Young, R., Cheung, Y. B., Fan, Y., Jorgensen, J. M., Kamng’ona, A. W., Chaima, D., Ashorn, U., Dewey, K. G., Maleta, K. M., et al. (2019) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000002435 · Cited by 12
“Moreover, the effect of morbidity on the microbiota could be mediated through increased antibiotics use, which has been shown to influence microbiota composition and an individual’s susceptibility to infections (12,29,30).”
BackgroundThe Nasopharyngeal and Gut Microbiota in Children in a Pediatric Otolaryngology Practice
Thapa, S., Runge, J. K., Venkatachalam, A., Denne, C., Luna, R. A., & Anon, J. B. (2020) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000002703 · Cited by 15
“These negative changes can persist for greater than 2 years in children on macrolide therapy and 6–12 months with penicillin-based medications.(16) Like the gut microbiome, the nasopharynx can also be affected by antibiotic therapy.”
BackgroundTalathi, S., Wilkinson, L. T., Meloni, K., Shroyer, M. C., Eipers, P. G., Pol, W. J. V. D., Martin, C. A., Dimmitt, R. A., Yi, N., Morrow, C. D., et al. (2020) · Nutrition in Clinical Practice · doi:10.1002/ncp.10594 · Cited by 12
Metadata
- Authors
- Korpela, K., Salonen, A., Virta, L. J., Kekkonen, R. A., Forslund, K., Bork, P., & de Vos, W. M.
- Affiliations
- University of Helsinki (FI)
- Social Insurance Institution (FI)
- Valio (Finland) (FI)
- Venue
- Nature Communications
- Published
- 2016-01-26
- Volume
- 7
- Issue
- 1
- Pages
- 10410-10410
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC4737757
- OpenAlex
- W2265709988
- Cited by
- 698
- References
- 64
- Citations by year
- 2026: 38 · 2025: 52 · 2024: 54 · 2023: 62 · 2022: 73 · 2021: 71 · 2020: 93 · 2019: 71 · 2018: 77 · 2017: 72 · 2016: 34
- FWCI
- 43.99
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (acceptedVersion)
- Socio-Environmental Systems Modeling (acceptedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Työväentutkimus Vuosikirja (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion, cc-by)
- Funders
- Alexander von Humboldt-Stiftung
- Academy of Finland (137389, 141140, 1272870)
- FP7 Ideas: European Research Council (250172)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Keywords
- gut microbiota, early-life antibiotic exposure, macrolides, penicillin, preschool children, asthma risk, bile salt hydrolase, macrolide resistance, actinobacteria, Bacteroidetes, Proteobacteria, microbiota composition, antibiotic prescribing
- MeSH terms
- Gastrointestinal Microbiome, Anti-Bacterial Agents, Bacteria, Bacterial Infections, Child, Child, Preschool, Day Care, Medical, Feces, Female, Finland, Humans, Male, Cohort Studies, Macrolides
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.